Omeros Stock

Omeros Equity

The The Equity of Omeros (OMER) as of Aug 14, 2026 is -121.23 M USD. In the previous year, The Equity was -182.61 M USD — a change of -33.61% (higher).

Equity

-121.23 MUSD

YoY

-33.61%

Last updated:

In 2026, Omeros's equity was -121.23 M USD, a -33.61% increase from the -182.61 M USD equity in the previous year.

Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Omeros's Equity

Omeros's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Omeros's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Omeros's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Omeros's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Omeros’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Omeros stock

The Equity of Omeros is -121.23 M USD in 2026.

The Equity of Omeros changed from -182.61 M USD to -121.23 M USD, representing a -33.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Omeros since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Omeros historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Omeros

All Key Metrics — Omeros